Related Experiment Video
Updated: Jun 6, 2026
07:11
Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Reduced pulmonary function is age-dependent in the rat lung in normoxia
G Petruccelli1, V Verratti, J Antosiewicz
1Department of Neuroscience and Imaging, G. d'Annunzio University, Campus Madonna delle Piane, Chieti, Italy.
European Journal of Medical Research
|December 15, 2010
Summary
Aging lungs show increased apoptosis markers like p53 and CPP32, but also activate survival pathways such as vascular endothelial growth factor (VEGF) and pIkB-α to counteract cell death.
Area of Science:
- Cellular Biology
- Aging Research
- Molecular Mechanisms
Background:
- Oxygen transport is vital for cellular respiration and enzymatic functions.
- Aging involves cell elimination and adaptation to stress.
- Cellular responses to aging are critical for tissue homeostasis.
Purpose of the Study:
- Investigate molecular changes in aging rat lungs.
- Examine the expression of hypoxia-inducible factor (HIF), VEGF, p53, p66Shc, CPP32, and pIkB-α during aging.
- Understand the interplay between apoptosis and survival mechanisms in the aging lung.
Main Methods:
- Utilized 12 male Wistar rats, aged 3 and 24 months.
- Analyzed lung tissues using TUNEL and Western blotting.
- Compared molecular markers between young and old rat lung specimens.
Main Results:
- Old rats exhibited significantly higher expressions of p53, p66Shc, and CPP32 compared to young rats.
- Vascular endothelial growth factor (VEGF) and pIkB-α expressions were also elevated in older rats.
- These findings indicate increased apoptosis and compensatory survival responses in aging lungs.
Conclusions:
- Aging rat lungs demonstrate elevated apoptosis markers (p53, p66Shc, CPP32).
- The lung activates survival pathways (VEGF, pIkB-α) to counteract age-related apoptosis.
- An intrinsic life-support system emerges in the aging lung to manage cellular stress.
Related Concept Videos
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation